Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001230724-25-000003
Filing Date
2025-02-21
Accepted
2025-02-21 20:14:05
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740186837.html 4  
1 FORM 4 wk-form4_1740186837.xml 4 3992
  Complete submission text file 0001230724-25-000003.txt   5458
Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address
GUGGENHIME ANDREW (Reporting) CIK: 0001230724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 25653842

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)